| Dr Michael M Krinsky, MD | |
|
580 Cottage Grove Rd, Bloomfield, CT 06002-3088 | |
| (860) 243-9709 | |
| (860) 243-2522 |
| Full Name | Dr Michael M Krinsky |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 580 Cottage Grove Rd, Bloomfield, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508898339 | NPI | - | NPPES |
| 714856 | Other | CONNECTICARE | |
| 0P0200 | Other | HEALTHNET | |
| 010018133CT01 | Other | BCBS ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 18133 (Connecticut) | Primary |
| Entity Name | Prospect Ct Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144677568 PECOS PAC ID: 7416244496 Enrollment ID: O20160919001322 |
News Archive
The recent BREXIT vote in the UK threatens to disrupt scientific progress and clinical advances in the development of innovative gene and cell therapies.
A new strategy to reduce the spread of COVID-19 employs a mobile robot that detects people in crowds who are not observing social-distancing rules, navigates to them, and encourages them to move apart.
Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference.
Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael M Krinsky, MD 580 Cottage Grove Rd, Bloomfield, CT 06002-3088 Ph: (860) 243-9709 | Dr Michael M Krinsky, MD 580 Cottage Grove Rd, Bloomfield, CT 06002-3088 Ph: (860) 243-9709 |
News Archive
The recent BREXIT vote in the UK threatens to disrupt scientific progress and clinical advances in the development of innovative gene and cell therapies.
A new strategy to reduce the spread of COVID-19 employs a mobile robot that detects people in crowds who are not observing social-distancing rules, navigates to them, and encourages them to move apart.
Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference.
Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
› Verified 7 days ago
Mr. Gregory Warwick Taylor, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 34 Jerome Ave Ste 204, Bloomfield, CT 06002 Phone: 860-966-9680 Fax: 860-206-6075 | |
Richard Judd Miller, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Northwestern Dr, Bloomfield, CT 06002 Phone: 860-243-3477 Fax: 860-793-3500 | |
Mrs. Jessica Listorti, PMHNP Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 693 Bloomfield Ave Ste 101, Bloomfield, CT 06002 Phone: 860-697-3372 | |
Ranjani Kurukulasuriya, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 693 Bloomfield Ave, Bloomfield, CT 06002 Phone: 860-243-6584 Fax: 860-243-6591 |